Als | search
Click here to view Als news from 60+ newspapers.
Bookmark or Share
May is ALS Awareness Month, a time to reflect on the role of regenerative medicine research in advancing understanding and treatment of amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease. This neurodegenerative disorder causes nerve cells in the brain and spinal cord to die, blocking signals to the muscles. More @Wikipedia
Get the latest news about Als from the top news sites, aggregators and blogs. Also included are videos, photos, and websites related to Als .
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.
- Science Saturday: How regenerative medicine is advancing ALS researchMay is ALS Awareness Month, a time to reflect on the role of regenerative medicine research in advancing understanding and treatment of amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease. This neurodegenerative disorder causes nerve cells in the brain and spinal cord to die, blocking signals to the muscles.
- Esclerosis lateral amiotrófica - Síntomas y causas - Mayo ClinicAmyotrophic lateral sclerosis (ALS) fact sheet. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet. Accessed Feb. 16, 2023. Environmental factors.
- Amyotrophic lateral sclerosis (ALS) - Symptoms and causesAmyotrophic lateral sclerosis (a-my-o-TROE-fik LAT-ur-ul skluh-ROE-sis), known as ALS, is a nervous system disease that affects nerve cells in the brain and spinal cord. ALS causes loss of muscle control.
- التصلب الجانبي الضموري (ALS) - Mayo Clinicأثناء تفاقم المرض، يتسبب التصلب الجانبي الضموري als في حدوث مضاعفات، مثل: مشكلات التنفس. يؤدي التصلب الجانبي الضموري مع مرور الوقت إلى ضعف العضلات التي يستخدمها الجسم في التنفس.
- Mayo Clinic awarded federal grant to study experimental ALS drugMayo Clinic in Florida has received a grant to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to an experimental drug over six months.
More
